Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06523647

Clinical Efficacy of Ustekinumab in Crohn's Disease

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Kazakhstan Scientific Society for Study of intestine diseases · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components.

Conditions

Timeline

Start date
2023-06-27
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-07-26
Last updated
2024-07-26

Locations

4 sites across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT06523647. Inclusion in this directory is not an endorsement.